These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6244933)

  • 1. Thyrotropin binding to rat thyroid membranes: reduced capacity associated with goitrogenesis.
    Witte A; Henderson B; Zakarija M; McKenzie JM
    Endocrinology; 1980 May; 106(5):1489-97. PubMed ID: 6244933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cholera toxin on in vitro refractoriness to thyrotropin of thyroids from rats fed propylthiouracil.
    Zakarija M; Witte A; McKenzie JM
    Endocrinology; 1980 Dec; 107(6):2045-50. PubMed ID: 6253287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
    Denereaz N; Lemarchand-Beraud T
    Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sulfhydryl groups in thyrotropin binding and adenylate cyclase activities of thyroid plasma membranes.
    Ozawa Y; Chopra IJ; Solomon DH; Smith F
    Endocrinology; 1979 Nov; 105(5):1221-5. PubMed ID: 226349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH; Gerend PL; Goretzki P; Nissenson RA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary thyrotropin (TSH) rebound phenomenon and kinetics of secretion in the goitrous rat: differential effects of thyroxine on synthesis and release of TSH.
    D'Angelo SA; Paul DH; Wall NR; Lombardi DM
    Endocrinology; 1976 Oct; 99(4):935-43. PubMed ID: 976195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive regulation of the guinea pig thyrotropin receptor.
    Davies TF
    Endocrinology; 1985 Jul; 117(1):201-7. PubMed ID: 2988915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
    Mandato E; Meldolesi MF; Macchia V
    Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
    Hoermann R; Amir SM; Ingbar SH
    Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroglobulin inhibition of thyrotropin binding to thyroid plasma membrane.
    Hashizume K; Fenzi G; DeGroot LJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):679-85. PubMed ID: 225342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties and regulation of the thyrotropin receptor in the FRTL5 rat thyroid cell line.
    Tramontano D; Ingbar SH
    Endocrinology; 1986 May; 118(5):1945-51. PubMed ID: 3009143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH; Gerend PL; Nissenson RA
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thyrotropin and cholera toxin on the thyroidal adenylate cyclase-adenosine 3',5'-monophosphate system.
    Holmes SD; Titus G; Chou M; Field JB
    Endocrinology; 1980 Dec; 107(6):2076-81. PubMed ID: 6253290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion.
    Tate RL; Schwartz HI; Holmes JM; Kohn LD
    J Biol Chem; 1975 Aug; 250(16):6509-15. PubMed ID: 169248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sialic acid on adenylate cyclase activity and thyrotropin-receptor binding in human thyroid membranes.
    Adler GM
    Acta Biochim Pol; 1978; 25(4):343-7. PubMed ID: 220831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of thyrotropin receptor from thyroid plasma membranes: effect of hydrocortisone, propranolol, and adenosine 3',5'-monophosphate.
    Hashizume K; DeGroot LJ
    Endocrinology; 1980 May; 106(5):1463-8. PubMed ID: 6244931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.